Pharma

Russia’s Pharmstandard To Spin Off Over-The-Counter Business

Saltigo to Provide Contract Manufacturing Services for Daiichi Sankyo

Saltigo has signed an agreement with Tokyo-based Daiichi Sankyo for the provision of contract manufacturing services; this comes ahead of Daiichi Sankyo's plans to commercialize one of its novel drug pipeline projects.

GlaxoSmithKline Under Investigation in China

Sanovel Up For Sale

European Medicines Agency Pave Way for Biosimilar Drug Breakthrough

Merck Serono Establishes Immunotherapy Platform

Eisai Pulls Fycompa from German Market after Pricing Tiff

ChemOutsourcing: An Annual Cult Classic

Securing Product Supply in the Pharmaceutical Industry

Realignment of the Pharmaceutical Supply Chain in Japan

Breaking New Ground

Global Meets Local in Austria

Codexis Sees Success in Pharma Business...

Chemical Industry’s Expectations for the U.S. Business Climate in 2013

Consumer Healthcare

Social Media in Pharmaceutical Companies

Saltigo Realigns Strategy

Saltigo, the custom manufacturing business of Lanxess' Advanced Intermediates segment, which achieved total sales of €1.5 billion in 2011, has realigned its strategy.

Manufacturing of HPAPIs and ADC Toxins for the Drugs of Tomorrow

India and China support Contract Manufacturing

PharmaChemical Ireland Strategy on Track

Expect More

The Future of Fine Chemical Production

Changing Times

Impact of New Regulations on Global Antibiotics Production

Learning From The Cliff

Siegfried acquires Alliance Medical Products

Valeant Withdraws Its Bid For ISTA Pharmaceuticals

What Pharma Can Learn from the Tobacco Industry

Interoperability in the Pharma Supply Chain

Saltigo Examines the State of Custom Manufacturing in the New Year

Optimism Springs Eternal - 2011 was a year fraught with uncertainties, and many industries are wearily eyeing the year to come.

EU Agency Issues Guideline on Biosimilar MS Drugs

Counterfeit Pharmaceuticals

Pharma Asks The Money Question Earlier For New Drugs

AstraZeneca, Novartis and Sanofi Douse Hopes For New Drugs

Healthcare Reform in the U.S.: What Supreme Court Ruling Could Mean